We further investigated the correlations between these atherogenic indices and circulating levels of VEGF-A, VEGF-C, VEGF-D, and PlGF in patients with DM with and without DR to elucidate disease mechanisms that can be translated to novel therapeutic targets for DR. The gene discussed is VEGFD; the disease is diabetes mellitus.